LED Dental's oral screener:
This article was originally published in Clinica
LED Dental has received US FDA 510(k) clearance to expand the indications for its VELscope oral cancer screening system to help detect lesions that may not be visible under traditional white light examinations - including precancerous and cancerous growths - and to help determine surgical margins. The device, which was previously cleared by the FDA in 2006 for oral mucosal examination, is used by a dentist or healthcare provider as an adjunct to traditional examination by incandescent light. It uses a narrow band of high-energy blue light and specialised filter technology, said the firm, a wholly-owned subsidiary of Vancouver, Canada-based LED Medical Diagnostics.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.